Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    24239220 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma
Condition: Disease, Hodgkin
Interventions: Drug: brentuximab vedotin;   Drug: doxorubicin;   Drug: vinblastine;   Drug: dacarbazine;   Drug: bleomycin

Indicates status has not been verified in more than two years